Search all trials

Find therapies in clinical trials near you – page 34

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

Study of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate

Contact Research Centre

Cholangiocarcinoma

Not recruiting

Registered drugNo placebo

Study of cisplatin, gemcitabine and rilvegostomig treatment in patients with high-risk resectable intrahepatic cholangiocarcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Hypersomnia

Not recruiting

Investigational

Study of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia

Investigational

France

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Inclisiran

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

InvestigationalNo placebo

Study of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:PUCOTENLIMAB

Contact Research Centre

Kidney transplant rejection

Not recruiting

Registered drug

Study of Felzartamab for Patients with Late Antibody-Mediated Rejection After Kidney Transplant

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Felzartamab

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

Investigational

France

Participants:18–64 years · 65+ years
Substances:PF-07868489

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug

France

Participants:18–64 years

Contact Research Centre

Pleural mesothelioma malignant

Not recruiting

InvestigationalNo placebo

Study of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ivonescimab

Contact Research Centre

Hereditary angioedema

Not recruiting

Registered drug

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lonvoguran

Contact Research Centre

Mastocytosis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Masitinib for Patients with Severe Systemic Mastocytosis Unresponsive to Treatment

Investigational

France

Participants:18–64 years · 65+ years
Substances:Masitinib

Contact Research Centre

Hereditary angioedema

Not recruiting

Registered drug

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deucrictibant

Contact Research Centre

Find therapies in clinical trials near you – page 34

654 trials match your criteria

Chronic obstructive pulmonary disease

Study of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)

Cholangiocarcinoma

Study of cisplatin, gemcitabine and rilvegostomig treatment in patients with high-risk resectable intrahepatic cholangiocarcinoma

Hypersomnia

Study of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia

Arteriosclerosis

Study of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)

Squamous cell carcinoma of head and neck

Study of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma

Kidney transplant rejection

Study of Felzartamab for Patients with Late Antibody-Mediated Rejection After Kidney Transplant

Pulmonary arterial hypertension

Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

Multiple sclerosis

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Pleural mesothelioma malignant

Study of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy

Hereditary angioedema

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Mastocytosis

Study on the Effectiveness and Safety of Masitinib for Patients with Severe Systemic Mastocytosis Unresponsive to Treatment

Hereditary angioedema

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.